Ipilimumab Biosimilar: Expanding Access to CTLA-4 Inhibition Ipilimumab (Yervoy) is a monoclonal antibody targeting cytotoxic T-lymphocyte-associat … read more 9th Dec 2024 Shanza Riaz
Amatuximab Biosimilar: Advancing Mesothelin-Targeted Therapy for Cancer Amatuximab is a monoclonal antibody targeting mesothelin, a tumor-associated antigen o … read more 8th Dec 2024 Shanza Riaz
Iscalimab Biosimilar: Advancing CD40-Targeted Therapy for Immune Modulation Iscalimab (CFZ533) is a monoclonal antibody targeting CD40, a key receptor in the immu … read more 7th Dec 2024 Shanza Riaz
